 <h1>Leukine Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>sargramostim</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about sargramostim. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Leukine.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to sargramostim: injection powder for solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, sargramostim (the active ingredient contained in Leukine) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking sargramostim:</p><p>
<i>More common</i>
</p><ul>
<li>Black, tarry stools</li>
<li>bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>blood in the eye</li>
<li>bloody nose</li>
<li>blurred vision</li>
<li>body aches or pain</li>
<li>bone pain</li>
<li>chest pain</li>
<li>cloudy urine</li>
<li>congestion</li>
<li>cough</li>
<li>decrease in urine output or decrease in urine-concentrating ability</li>
<li>difficult or labored breathing</li>
<li>drowsiness</li>
<li>dry mouth</li>
<li>dryness or soreness of the throat</li>
<li>eye pain</li>
<li>fast, pounding, or irregular heartbeat or pulse</li>
<li>fever</li>
<li>flushed, dry skin</li>
<li>fruit-like breath odor</li>
<li>hoarseness</li>
<li>increased hunger</li>
<li>increased thirst</li>
<li>increased urination</li>
<li>irregular heartbeat</li>
<li>large amount of cholesterol in the blood</li>
<li>loss of appetite</li>
<li>mood or mental changes</li>
<li>muscle spasms</li>
<li>nausea</li>
<li>rapid weight gain</li>
<li>redness in whites of eyes</li>
<li>runny nose</li>
<li>stomach pain</li>
<li>sweating </li>
<li>tender, swollen glands in the neck</li>
<li>tightness in the chest</li>
<li>tingling of the hands or feet</li>
<li>trouble with swallowing</li>
<li>trembling</li>
<li>twitching</li>
<li>unusual tiredness or weakness</li>
<li>unusual weight gain or loss</li>
<li>voice changes</li>
<li>vomiting</li>
<li>vomiting of blood or material that looks like coffee grounds</li>
<li>yellow eyes or skin</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Chills</li>
<li>confusion</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>general feeling of illness</li>
<li>headache</li>
<li>pain in the chest, groin, or legs, especially the calves</li>
<li>severe, sudden headache</li>
<li>slurred speech</li>
<li>sudden loss of coordination</li>
<li>sudden, severe weakness or numbness in the arm or leg</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of sargramostim may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Diarrhea</li>
<li>difficulty in moving</li>
<li>fear or nervousness</li>
<li>itching skin</li>
<li>lack or loss of strength</li>
<li>muscle pain or stiffness</li>
<li>pain in the joints</li>
<li>trouble sleeping</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Bleeding, blistering, burning, coldness, discoloration of skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site</li>
<li>feeling of warmth</li>
<li>redness of the face, neck, arms, and occasionally, upper chest</li>
</ul><p>
<!-- end injection powder for solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to sargramostim: injectable powder for injection, injectable solution</i></p><h3>General</h3><p>The type and frequency of adverse events following induction in patients with acute myelogenous leukemia (AML) were similar between those treated with this drug and those taking placebo.<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fever (up to 95%), mucous membrane disorder (75%), asthenia (up to 66%), malaise (57%), edema (up to 34%), chills (up to 25%), pain (17%), chest pain (15%), peripheral edema (up to 15%)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 90%), diarrhea (up to 89%), vomiting (up to 85%), stomatitis (up to 62%), abdominal pain (38%), gastrointestinal disorder (37%), gastrointestinal hemorrhage (up to 27%), dyspepsia (17%), hematemesis (13%), dysphagia (11%)</p>
<p><b>Common</b> (1% to 10%): Constipation, abdominal distention<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Alopecia (up to 73%), rash (up to 70%), pruritus (23%)</p>
<p><b>Common</b> (1% to 10%): Petechia, sweats<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Infection (65%), allergy (12%), sepsis (11%)</p>
<p><b>Common</b> (1% to 10%): Neutralizing antibodies</p>
<p><b>Frequency not reported</b>: Allergic reaction, anaphylactoid reaction<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia (up to 54%), glucose high (41%), weight loss (37%), hyperglycemia (25%), cholesterol high (17%), hypomagnesemia (15%)</p>
<p><b>Common</b> (1% to 10%): Calcium low, weight gain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 36%), central nervous system disorder (11%), paresthesia (11%)</p>
<p><b>Frequency not reported</b>: Dizziness</p>
<p><b>Postmarketing reports</b>: Fainting<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypertension (34%), hemorrhage (up to 29%), pericardial effusion (25%), hypotension (13%), tachycardia (11%)</p>
<p><b>Postmarketing reports</b>: Arrhythmia, thrombosis<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Bilirubinemia (30%), liver damage (13%), ALT increased (13%)</p>
<p><b>Common</b> (1% to 10%): Alkaline phosphatase increased</p>
<p><b>Postmarketing reports</b>: Transient liver function abnormalities<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Dyspnea (28%), pharyngitis (23%), lung disorder (20%), epistaxis (17%), dyspnea (15%), rhinitis (11%)<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Albumin low (27%), blood dyscrasia (25%), thrombocytopenia (19%), leukopenia (17%)</p>
<p><b>Common</b> (1% to 10%): Agranulocytosis</p>
<p><b>Frequency not reported</b>: Anemia, serum proteins low, prothrombin time prolonged, progressive increase in circulating monocytes and promonocytes and blasts in the marrow</p>
<p><b>Postmarketing reports</b>: Eosinophilia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very common</b> (10% or more): BUN high (23%), creatinine increased (15%)</p>
<p><b>Common</b> (1% to 10%): Kidney function abnormal<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Bone pain (21%), arthralgia (up to 21%), myalgia (18%)</p>
<p><b>Common</b> (1% to 10%): Back pain</p>
<p><b>Postmarketing reports</b>: Joint pain<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Urinary tract disorder (14%)</p>
<p><b>Common</b> (1% to 10%): Hematuria<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (11%), anxiety (11%)<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Eye hemorrhage (11%)<sup>[Ref]</sup></p><h3>Local</h3><p><b>Postmarketing reports</b>: Injection site reactions<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Leukine (sargramostim)." Immunex Corporation, Seattle, WA. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Leukine (sargramostim)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: colony stimulating factors</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Leukine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Aplastic Anemia</li>
<li>Bone Marrow Transplantation</li>
<li>Bone Marrow Transplantation, Failure or Engraftment Delay</li>
<li>Bone Marrow Transplantation, Myeloid Reconstruction</li>
<li>Neutropenia Associated with Chemotherapy</li>
<li>Neutropenia Associated with Radiation</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to sargramostim: injectable powder for injection, injectable solution</i></p><h3>General</h3><p>The type and frequency of adverse events following induction in patients with acute myelogenous leukemia (AML) were similar between those treated with this drug and those taking placebo.<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fever (up to 95%), mucous membrane disorder (75%), asthenia (up to 66%), malaise (57%), edema (up to 34%), chills (up to 25%), pain (17%), chest pain (15%), peripheral edema (up to 15%)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 90%), diarrhea (up to 89%), vomiting (up to 85%), stomatitis (up to 62%), abdominal pain (38%), gastrointestinal disorder (37%), gastrointestinal hemorrhage (up to 27%), dyspepsia (17%), hematemesis (13%), dysphagia (11%)</p><p><b>Common</b> (1% to 10%): Constipation, abdominal distention<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Alopecia (up to 73%), rash (up to 70%), pruritus (23%)</p><p><b>Common</b> (1% to 10%): Petechia, sweats<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Infection (65%), allergy (12%), sepsis (11%)</p><p><b>Common</b> (1% to 10%): Neutralizing antibodies</p><p><b>Frequency not reported</b>: Allergic reaction, anaphylactoid reaction<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia (up to 54%), glucose high (41%), weight loss (37%), hyperglycemia (25%), cholesterol high (17%), hypomagnesemia (15%)</p><p><b>Common</b> (1% to 10%): Calcium low, weight gain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 36%), central nervous system disorder (11%), paresthesia (11%)</p><p><b>Frequency not reported</b>: Dizziness</p><p><b>Postmarketing reports</b>: Fainting<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypertension (34%), hemorrhage (up to 29%), pericardial effusion (25%), hypotension (13%), tachycardia (11%)</p><p><b>Postmarketing reports</b>: Arrhythmia, thrombosis<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Bilirubinemia (30%), liver damage (13%), ALT increased (13%)</p><p><b>Common</b> (1% to 10%): Alkaline phosphatase increased</p><p><b>Postmarketing reports</b>: Transient liver function abnormalities<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Dyspnea (28%), pharyngitis (23%), lung disorder (20%), epistaxis (17%), dyspnea (15%), rhinitis (11%)<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Albumin low (27%), blood dyscrasia (25%), thrombocytopenia (19%), leukopenia (17%)</p><p><b>Common</b> (1% to 10%): Agranulocytosis</p><p><b>Frequency not reported</b>: Anemia, serum proteins low, prothrombin time prolonged, progressive increase in circulating monocytes and promonocytes and blasts in the marrow</p><p><b>Postmarketing reports</b>: Eosinophilia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very common</b> (10% or more): BUN high (23%), creatinine increased (15%)</p><p><b>Common</b> (1% to 10%): Kidney function abnormal<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Bone pain (21%), arthralgia (up to 21%), myalgia (18%)</p><p><b>Common</b> (1% to 10%): Back pain</p><p><b>Postmarketing reports</b>: Joint pain<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Urinary tract disorder (14%)</p><p><b>Common</b> (1% to 10%): Hematuria<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (11%), anxiety (11%)<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Eye hemorrhage (11%)<sup>[Ref]</sup></p><h3>Local</h3><p><b>Postmarketing reports</b>: Injection site reactions<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Leukine (sargramostim)." Immunex Corporation, Seattle, WA. </p><h2>More about Leukine (sargramostim)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: colony stimulating factors</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Leukine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Aplastic Anemia</li>
<li>Bone Marrow Transplantation</li>
<li>Bone Marrow Transplantation, Failure or Engraftment Delay</li>
<li>Bone Marrow Transplantation, Myeloid Reconstruction</li>
<li>Neutropenia Associated with Chemotherapy</li>
<li>Neutropenia Associated with Radiation</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>